Dev Accelerator Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Dev Accelerator Ltd is ₹ 40.3 as of 18 Mar 15:30 . The P/E Ratio of Dev Accelerator Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Dev Accelerator Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Dev Accelerator Ltd for the Dec '25 is ₹ 62.04 crore as compare to the Sep '25 revenue of ₹ 54.54 crore. This represent the growth of 13.75% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dev Accelerator Ltd for the Dec '25 is ₹ 26.76 crore as compare to the Sep '25 ebitda of ₹ 29.13 crore. This represent the decline of -8.14% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dev Accelerator Ltd changed from ₹ -5.97 crore to ₹ -1.01 crore over 7 quarters. This represents a CAGR of -63.77% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Dev Accelerator Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Dev Accelerator Ltd

Dev Accelerator Limited originally started the business as a Limited Liability Partnership under the name and style of 'Dev Accelerator LLP' on September 14, 2017 under the Limited Liability Partnership Act, 2008, issued by the RoC. Subsequently, the Limited Liability Partnership was converted into a Private Limited Company and a Certificate of Incorporation dated September 05, 2020 was issued by the Registrar of Companies, Central Registration Centre under the name and style of Dev Accelerator Private Limited'.
The Company further was converted into a Public Limited Company and a fresh Certificate of Incorporation upon conversion to Public Limited dated September 3, 2024 was issued by the RoC, resulting the Company name was changed to its present name, Dev Accelerator Limited'. The Company is one of the largest flex space operators in terms of operational flex stock in Tier 2 markets.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Dev Accelerator Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Dev Accelerator Ltd or Genomic Valley Biotech Ltd?

Market cap of Dev Accelerator Ltd is 363 Cr while Market cap of Genomic Valley Biotech Ltd is 8 Cr

What are the key factors driving the stock performance of Dev Accelerator Ltd and Genomic Valley Biotech Ltd?

The stock performance of Dev Accelerator Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dev Accelerator Ltd and Genomic Valley Biotech Ltd?

As of March 18, 2026, the Dev Accelerator Ltd stock price is INR ₹40.3. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹28.43.

How do dividend payouts of Dev Accelerator Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Dev Accelerator Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.